Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs Unicycive Therapeutics, Inc. (UNCY)

Corbus Pharmaceuticals Holdings, Inc. and Unicycive Therapeutics, Inc. are both Biotechnology companies. Corbus Pharmaceuticals Holdings, Inc. and Unicycive Therapeutics, Inc. are of similar size ($144.1M and $134.0M). Across the 8 metrics below, Unicycive Therapeutics, Inc. leads on 5 and Corbus Pharmaceuticals Holdings, Inc. on 3.

Valuation

Metric CRBP UNCY Biotechnology median
P/E n/m n/m 7.88
P/S 89.99 n/m 11.47
P/B 1.36 2.38 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 22.77 n/m 10.73
Earnings yield (86.69%) (37.15%) (28.84%)
Free cash flow yield (62.56%) (21.97%) (23.03%)

Profitability

Metric CRBP UNCY Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (95.58%) (101.07%) (57.72%)
Return on assets (80.85%) (69.05%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBP UNCY Biotechnology median
Revenue growth (TTM) (73.69%) — 5.64%
EPS growth (last fiscal year) (60.33%) 70.18% —
Revenue growth, 5-year CAGR (14.34%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBP UNCY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.71 3.81 4.73
Net debt to EBITDA 1.90 1.43 0.96

Dividend

Metric CRBP UNCY Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CRBP UNCY Biotechnology median
Market cap 144.09m 133.98m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack